
The company plans to continue with a lower dose and a change in the pre-treatment regimen after a trial participant died earlier this year.

The company plans to continue with a lower dose and a change in the pre-treatment regimen after a trial participant died earlier this year.
© 2023 LBNN - All rights reserved.